Abstract
The high mortality rate of patients with diabetic foot ulcers is urging the appearance of an effective biomedical drug. Senescence is one of the major reasons of aging-induced decline in the diabetic wound. Our previous studies have demonstrated the anti-senescence effect of secretomes derived from human fetal mesenchymal stem cells (hfMSC). The present study tends to explore the potential role of hfMSC secretome (HFS) in wound healing through anti-aging. Meanwhile, we try to overcome several obstacles in the clinical application of stem cell secretome. A verticle bioreactor and microcarriers are employed to expand hfMSC and produce the HFS on a large scale. The HFS was then subjected to lyophilization (L-HFS). The PLGA (poly lactic-co-glycolic acid) particles were used to encapsulate and protect L-HFS from degradation in the streptozotocin (STZ)-induced diabetic rat model. Results showed that HFS-PLGA significantly enhanced wound healing by promoting vascularization and inhibiting inflammation in the skin wound bed. We further analyzed the contents of HFS. Isobaric tag for relative and absolute quantitation (ITRAQ) and label-free methods were used to identify peptides in the secretome. Bioinformatics analysis indicated that exosome production-related singling pathways and heat-shock protein family could be used as bio-functional markers and quality control for stem cell secretome production.
Original language | English |
---|---|
Article number | e10354 |
Number of pages | 20 |
Journal | Bioengineering and Translational Medicine |
Volume | 8 |
Issue number | 1 |
Early online date | 21 Jun 2022 |
DOIs | |
Publication status | Published - Jan 2023 |
Bibliographical note
Funding Information:Guangzhou Municipal Science and Technology Bureau, CHINA, Grant/Award Number: 202102021247; Hong Kong Innovation Technology Commission Funds, Grant/Award Number: PRP/050/19FX; Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Grant/Award Number: SMART program; Research Grants Council, University Grants Committee of Hong Kong Special Administrative, Grant/Award Numbers: AoE/M‐402/20, T13‐402/17‐N; Key Laboratory of Guangdong Higher Education Institutes, Grant/Award Numbers: 19FX, T13‐402 Funding information
Funding Information:
This work was fully supported by grants from the University Grants Committee, Research Grants Council of the Hong Kong Special Administrative Region, China (T13‐402/17‐N and AoE/M‐402/20); partially supported by grants from Hong Kong Innovation Technology Commission Funds (PRP/050/19FX). This study also received support from the SMART program, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong. This work was also supported by grants from Guangzhou science and technology bureau, CHINA (202102021247).
Publisher Copyright:
© 2022 The Authors. Bioengineering & Translational Medicine published by Wiley Periodicals LLC on behalf of American Institute of Chemical Engineers.
Funding
Guangzhou Municipal Science and Technology Bureau, CHINA, Grant/Award Number: 202102021247; Hong Kong Innovation Technology Commission Funds, Grant/Award Number: PRP/050/19FX; Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Grant/Award Number: SMART program; Research Grants Council, University Grants Committee of Hong Kong Special Administrative, Grant/Award Numbers: AoE/M‐402/20, T13‐402/17‐N; Key Laboratory of Guangdong Higher Education Institutes, Grant/Award Numbers: 19FX, T13‐402 Funding information This work was fully supported by grants from the University Grants Committee, Research Grants Council of the Hong Kong Special Administrative Region, China (T13‐402/17‐N and AoE/M‐402/20); partially supported by grants from Hong Kong Innovation Technology Commission Funds (PRP/050/19FX). This study also received support from the SMART program, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong. This work was also supported by grants from Guangzhou science and technology bureau, CHINA (202102021247).
Funders | Funder number |
---|---|
University Grants Committee, Research Grants Council of the Hong Kong Special Administrative Region, China | AoE/M-402/20, T13-402/17-N |
Chinese University of Hong Kong | |
Innovation and Technology Commission - Hong Kong | |
Guangzhou Municipal Science and Technology Bureau | 202102021247 |
Keywords
- bioreactor
- diabetic wound healing
- fetal mesenchymal stem cell secretome
- PLGA particles
- quality control